ea0005s5 | Clinical Endocrinology Trust Lecture | BES2003
Shalet S
GH replacement has been offered to children with GH deficiency (GHD) for 40 years; with time, however, and the increasing availability of recombinant derived GH, the threshold cut-off used to define GH status utilising provocative tests has been relaxed, leading to diagnostic dilemmas; this is particularly relevant as the growth velocity of a child, short from almost any cause, can be improved if he/she receives enough GH.The advent of adult GH replacement paradoxically is...